How much funding has Daye raised?

Daye has raised $17.0M in total funding, most recently a Series A round.

Who are Daye's investors?

Daye's investors include Hambro Perks Limited, Khosla Ventures, MassMutual Ventures.

Where is Daye headquartered?

Daye is headquartered in London, England, United Kingdom.

What industry is Daye in?

Daye operates in Healthcare, Medical.

Daye

Bridging the gender health gap through science

London, United Kingdom · Founded 2018 · $17.0M raised

Healthcare

Medical

Headquarters: London, England
Employees: 51–200
Founded: 2018
Business Model: B2C

Website: yourdaye.com
Total Funding: $17.0M
Last Round: $11.5M Series AOct 2022
Rounds: 2

About

Daye is a femtech company bridging the gender health gap through science-backed gynae healthcare products. Its flagship product is an organic CBD-coated tampon clinically validated for menstrual pain relief and cleared by the FDA. Daye also offers at-home vaginal microbiome screening, probiotics, and hormonal health products, combining medical-grade standards with subscription-based consumer delivery.

Summary

Daye is a Healthcare company based in London, United Kingdom, founded in 2018. It has raised $17.0M in total across 2 rounds, most recently a $11.5M Series A round in Oct 2022. Investors include Hambro Perks Limited, Khosla Ventures and MassMutual Ventures.

LinkedIn X (Twitter)